contestada

An infant with a congenital heart defect is receiving palivizumab (synagis). based on the nurses knowledge of medication, the purpose of this medication is to

Respuesta :

Synagis is a monoclonal antibody specific for RSV. Monthly administration is initiated to prevent infection with RSV.

Otras preguntas